Quest To Use AI In Drug Discovery Joins Sanofi and Exscientia

 
• By Sten Stovall

Sanofi hopes to use Exscientia's artificial intelligence (AI) platform to develop bispecific-small-molecule drugs for diabetes and associated metabolic conditions.

Ai hand
Sanofi Is Reaching Out To AI Specialist Exscientia

More from Strategy

More from Business